A subscription to JoVE is required to view this content. Sign in or start your free trial.
Polymersomes are self-assembled polymeric vesicles that are formed in spherical shapes to minimize Gibb's Free Energy. In the case of drug delivery, more elongated structures are beneficial. This protocol establishes methods to create more rod-like polymersomes, with elongated aspect ratios, using salt to induce osmotic pressure and reduce internal vesicle volumes.
Polymersomes are membrane-bound, bilayer vesicles created from amphiphilic block copolymers that can encapsulate both hydrophobic and hydrophilic payloads for drug delivery applications. Despite their promise, polymersomes are limited in application due to their spherical shape, which is not readily taken up by cells, as demonstrated by solid nanoparticle scientists. This article describes a salt-based method for increasing the aspect ratios of spherical poly(ethylene glycol) (PEG)- based polymersomes. This method can elongate polymersomes and ultimately control their final shape by adding sodium chloride in post-formation dialysis. Salt concentration can be varied, as described in this method, based on the hydrophobicity of the block copolymer being used as the base for the polymersome and the target shape. Elongated nanoparticles have the potential to better target the endothelium in larger diameter blood vessels, like veins, where margination is observed. This protocol can expand therapeutic nanoparticle applications by utilizing elongation techniques in tandem with the dual-loading, long-circulating benefits of polymersomes.
Shape modulation is a relatively new and efficient way to improve nanoparticle-mediated drug delivery. Not only does the change in morphology increase the surface area of particles, which in turn allows for a greater carrying capacity, but it also has implications across the board to improve stability, circulation time, bioavailability, molecular targeting, and controlled release1. Polymersomes, the nanoparticle of focus in this method, tend to thermodynamically self-assemble into a spherical shape, which has proven to be impractical in cellular uptake and is more easily detected in the immune system as a foreign body. Being able to elongate th....
1. Spherical polymersome formation using a solvent injection method
Table 2 presents expected results when following the protocol step 1. Note that DMSO is used as a solvent for both PEG-PLA and PEG-PLGA in polymersomes formation. Deviation from this solvent is possible, as other water-miscible solvents will dissolve the copolymers but is expected to change results. It is expected that PDI will be less than 0.2, indicating the formation of monodisperse polymersomes17. Note that increasing hydrophobicity leads to increased deviation in both polymer.......
Self-assembled systems are notoriously uncontrollable. Their final properties, including size, shape, and structure, are driven by the chosen amphiphile's hydrophobic properties and the solvent environment selected. Amphiphilic block copolymers tend towards spherical shapes, which minimizes Gibb's free energy and leads to the thermodynamic equilibrium23, thus forming polymersomes. Because of their equilibrium nature, polymersomes are significantly more challenging to elongate or alter in s.......
The authors have nothing to disclose.
This project was funded in part by the National Institutes of Health Project number 5P20GM103499-19 through the Student Initiated Research Project Program. This work was also partially supported by Clemson's Creative Inquiry Program. We also acknowledge Nicholas L'Amoreaux and Aon Ali who initially worked on creating this protocol, publishing their first paper cited here14.
....Name | Company | Catalog Number | Comments |
15*45 vials screw thread w/cap attached | Fisherbrand | 9609104000 | |
Dimethyl Sulfoxide | Fisher Chemical | D128-1 | |
Dimethyl Sulfoxide | BDH | BDH1115-1LP | |
Isoremp stirrers, hotplates, and stirring hotplates | Fisher scientific | CIC00008110V19 | |
LEGATO 130 SYRINGE PUMP | kd Scientific | 788130 | |
PEG(1000)-b-PLA(5000), Diblock Polymer | Polysciences Inc | 24381-1 | note the molecular weights when replicating |
Poly(ethylene glycol) (2000) Methyl ether-block-poly(lactide-co-glycolide) (4500) | Sigma aldrich | 764825-1G | note the molecular weights when replicating |
Single-Use Syringe/BD PrecisionGlide Needle combination, sterile, BD medical | BD medical | BD305620 | Tuberculin |
Sodium Chloride | BDH | BDH9286 | |
Zetasizer Nano ZS | Malvern |
Request permission to reuse the text or figures of this JoVE article
Request PermissionThis article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2025 MyJoVE Corporation. All rights reserved